Capital Com MENA Securities Trading LLC is regulated by the Capital Market Authority.
Open platformOpen platform

Natural Products Canada invests $1.02 million in five early-stage companies

By Public Technologies
  • Natural Products Canada is investing $1.02 million across five early-stage companies, supporting $2.54 million in project activities.
  • Novagevity receives $344,602 to validate and optimize Sperri Control and Sperri Kids, its plant-based nutritional beverages.
  • Catalera Biosolutions receives $137,989 to validate its biological seed-coating technology under Canadian field conditions.
  • Sustainable Bioproducts Innovations receives $349,958 to scale production and validate its plant-based fat replacement for commercial food applications.
  • Toothpod receives $25,000 for market strategy; Naturfect Natural Solutions gets $158,781 for a plant-based laundry detergent scale-up trial.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Natural Products Canada published the original content used to generate this news brief on October 22, 2026, and is solely responsible for the information contained therein.

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.